Wednesday 24 April 2019 - 22:57
In Business 39 Years - Since 1980
LC Labs Product Usage Update: Rapamycin, Doxorubicin, Paclitaxel, and 33 Others -- April 17, 2019.
FREE SHIPPING TO THE U.S. AND 33 OTHER COUNTRIES! [Read more].
Search:
N-9055 Nintedanib, Ethanesulfonate Salt, >99%
Synonyms : [BIBF1120 Esylate] [Intedanib Esylate] [Nintedanib Esylate]
Related Terms : [OFEV] [Vargatef]
- Size
- US $
- €
- £
- ¥
- 25 mg
- 41
- 36
- 31
- 4,600
- In stock
- 50 mg
- 56
- 49
- 43
- 6,300
- In stock
- 100 mg
- 72
- 64
- 55
- 8,100
- In stock
- 200 mg
- 108
- 96
- 83
- 12,100
- In stock
- 500 mg
- 192
- 171
- 148
- 21,500
- In stock
- 1 g
- 279
- 248
- 215
- 31,200
- In stock
- 2 g
- 494
- 440
- 381
- 55,300
- In stock
- 5 g
- 980
- 874
- 756
- 109,600
- In stock
Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.
To receive a Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities
Free Shipping and Handling to the U.S. and 33 Other Countries
- M.W. 649.76
- C31H33N5O4•C2H6O3S
- [656247-18-6]
- M.I. 15: 5031
Storage: Store at or below -20 ºC. Solubility: Soluble in DMSO at 25 mg/mL with warming; soluble in ethanol at 8 mg/mL with warming; soluble in water at 25 mg/mL with warming; buffers, serum, or other additives may increase or decrease the aqueous solubility. Disposal: A.
- This research compound is the ethanesulfonate salt form of nintedanib; please see the other form of this product, Nintedanib, Free Base, Cat. No. N-9077, for further technical information about both of these research compounds.
- This nintedanib product is the ethanesulfonate salt, whose CAS number is given above. The CAS number of the Nintedanib, Free Base form is 656247-17-5.
- Nintedanib is the active ingredient in the drug formulation designated by the trade name Vargatef®. This drug has been used in human clinical trials for patients with non-small cell lung, colorectal, uterine, endometrial, ovarian, and cervical cancer and multiple myeloma. NOTE: THE NINTEDANIB, ETHANESULFONATE SALT RESEARCH COMPOUND SOLD BY LC LABORATORIES IS NOT VARGATEF®, AND IS NOT FOR HUMAN USE.
- Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use.
- This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
- Not available in some countries; not available to some institutions; not available for some uses.
